A Splice of Life Science Marketing

Matt Wilkinson and Jasmine Griuia-Gray | Strivenn
  • 0.0 (0)
  • Marketing
  • Updated Weekly

Welcome to the Splice of Life Science Marketing Podcast. With your hosts Matt Wilkinson and Jasmine Gruia-Gray. This is the show for scientists who've stepped out of the lab and into marketing, learning the ropes as they go.

  1. 22h ago

    S2 Ep35: The Empty Chair Argues Back

    Shownotes: Jeff Bezos kept an empty chair in early Amazon meetings so everyone remembered the customer who was missing. Most decision rooms in life science still have the absence, and the research that could fill it sits unread on a shared drive. For product managers, marketing leaders and commercial teams at life science tools and diagnostics companies. Jasmine Gruia-Gray challenges Matt Wilkinson on his blog The Empty Chair, opening with research showing that genuine dissent moves a group further than an assigned devil's advocate. They test whether a synthetic buyer is just another assigned critic, why each function remembers a different outlier customer, and why sales cannot simply play the customer. They also draw the line where synthetic buyers stop and real customer conversations take over. The empty chair reminded the room the customer was missing; a synthetic buyer built on your own research now lets it answer back. What you will learn:- Why each function remembers a different outlier customer, and how that steers decisions towards the wrong problem- How organisational gravity wears down the people fighting to bring voice of customer into the room- Why a grounded synthetic buyer agrees or disagrees according to the evidence you give it- Where synthetic customers stop: pressure-test with them, then go back to real buyers before you commit- A first step you can take this week with a decision already on the calendar and research you already hold Chapters:[00:27] The empty chair and the assigned critic[04:17] Why the chair stays empty[06:24] One chair or five: the buying committee[07:21] Why not ask sales to play the customer?[09:36] Will a synthetic customer just agree with you?[11:54] Assigned dissent and the synthetic buyer[12:53] Will synthetic buyers eat the research budget?[14:49] What to do next week[16:03] Speed or trust: a client example Keywords: synthetic customers, synthetic buyer, voice of customer, life science marketing, product marketing, buying committee, confirmation bias, organisational gravity, customer research, AI in marketing, go-to-market strategy, decision making Watch the full conversation, subscribe to A Splice of Life Science Marketing for new episodes, and read The Empty Chair and more at strivenn.com.

    S2 Ep35: The Empty Chair Argues Back

  2. 6d ago

    S2 Ep 34: Botsitting: Where Your AI Time Savings Actually Go

    Your fastest AI user may also be your most expensive one. Workers say AI saves them around 11 hours a week, then hand roughly 6.4 of those hours straight back to checking and correcting the output. Matt Wilkinson and Jasmine Gruia-Gray call that hidden labour botsitting, and most teams have no idea how much of it they are doing. For life science marketers and product managers who have rolled out AI and are still waiting for the productivity to show up in the numbers. Matt and Jasmine unpack the Glean Work AI Index 2026 and the Harvard Business Review research on workslop, AI output that looks finished and isn't. They explore why AI has no sense of when to stop, why experienced teams still spend heavily on supervision, and why the humble marketing brief is back as the most useful input you can give a model. The episode closes with practical steps to size the botsitting tax and budget review time before launch. Key idea: AI saves time, but half of it goes back into botsitting unless humans own direction and judgement. What you will learn: - Why workers report large AI time savings while few organisations see measurable gains - What workslop costs in cleanup time per piece and across a large company - Why AI produces fluent, confident output that still needs a human to decide when it is done - How a proper brief built around persona and pain points reduces rework - How to put a rough number on the time your team spends fixing AI output - How to triage tasks so regulated claims and buyer-facing content get review time budgeted up front Chapters: 00:00 Introduction 00:25 What botsitting is and what the Glean data shows 04:40 Workslop and the real cost of cleanup 05:42 The Sisyphus problem 07:05 Creating for volume and the AI summary loop 09:50 Will botsitting fade as teams mature? 11:27 Is this just good editing? 13:20 Context, guidelines and the brief 18:50 Practical advice: quantify the tax and triage the work 20:49 When fixing AI takes longer than writing it 22:47 Closing thoughts Keywords: botsitting, workslop, AI productivity, life science marketing, AI ROI, context engineering, prompt engineering, marketing brief, synthetic customers, Glean Work AI Index, B2B marketing AI, AI governance Watch the full episode, subscribe to A Splice of Life Science Marketing, and visit strivenn.com to see how Strivenn helps life science teams turn AI activity into commercial results.

  3. Sep 22

    S2 Ep31: Watch, Don't Ask: Closing the Say-Do Gap in Voice of Customer

    Life science product leaders: surveys show what customers believe they do. Ethnography shows what they actually do, and that's the real gap. Shownotes A hand hygiene study at King's College London found that people who said they always washed their hands were caught doing it only a quarter as often as they claimed. The same gap hides in your customers' labs, in the habits they stopped noticing years ago. Who this is for: product managers, marketing leaders and commercial teams at life science tools companies who rely on customer surveys for voice of customer. Matt Wilkinson and Jasmine Gruia-Gray unpack why ethnographic observation catches what surveys structurally cannot: the workarounds, post-it note fixes and unspoken frustrations that scientists no longer register as decisions. They walk through real cases, from a DNA sequence copy-paste error to a vacuum cleaner built for asthmatics, and lay out the three tiers of customer access and what to do when a site visit turns up nothing at all. Key idea: Surveys tell you what customers believe they do. Ethnography shows you what they actually do, and that gap is where the real product insight lives. Why the King's College hand-washing study proves surveys measure self-belief, not behaviourThe two interview questions that surface habits a scientist has stopped noticingHow Miele's engineers turned an invisible vacuuming habit into a featureThe three tiers of customer access, from full lab entry to a phone call, and how to work each oneWhat it means when a site visit turns up no workarounds at allThree things a product manager should walk out of every customer visit with [00:07] The say-do gap: what the King's College study reveals [02:05] Where this idea came from: habits nobody writes down [03:00] How to interview someone into revealing a hidden habit [03:31] The Miele vacuum cleaner: when watching beats the survey [06:41] Why sales never sees what product needs to see [07:23] Reading a company's hierarchy before you ask a single question [09:30] Hierarchy, SOPs and the DNA sequence copy-paste problem [12:20] Watching for emotion: body language and frustration in the lab [14:49] The three access tiers and the limits of observation [17:26] Ethnography and survey are complementary, not competing [18:13] Access is shrinking: adapting to regulated sites [19:18] What to walk out of a site visit with, and what nothing means [22:10] The habit that wastes the most time, and where to read more Keywords: ethnographic research, voice of customer, life science marketing, product management, customer discovery, say-do gap, user research, qualitative research, life science product management, buyer insight, market research methods, commercial launch Watch the full conversation, subscribe to A Splice of Life Science Marketing for weekly episodes on buyer presence and commercial launch, and read the full article, What Ethnography Actually Gets You and What It Costs, at: https://strivenn.com/thinking/what-ethnography-actually-gets-you. If your team keeps filing commercial visits as voice of customer, book a free growth consultation at strivenn.com/contact.

    S2 Ep31: Watch, Don't Ask: Closing the Say-Do Gap in Voice of Customer

  4. Sep 14

    S2 Ep 32 Return on Conversation: Brooke B. Sellas talks social listening and life sciences marketing

    Brooke B. Sellas shows life science marketers how two-way conversations on social produce measurable return. Your leadership team says there is no return on social media. They are probably right, because almost every brand is standing in the middle of the room waiting for people to come to them. Brooke Sellas of B Squared Media joins Matt Wilkinson and Jasmine Gruia-Gray to explain return on conversation, the framework she built from social penetration theory and fifteen years of work with middle market and enterprise brands. She walks through the CARE framework, the BIC listening method, why the negative conversation is the only real catalyst for change, and how response speed should be triaged in regulated sectors. What you will learn: How return on conversation reframes social from a content problem into an acquisition and retention problemThe four levels of self-disclosure, and why clichés and facts leave a relationship exactly where it startedThe BIC method for social listening, covering brand, industry and competitor keywordsWhy you should open your listening work with negative sentiment, illustrated by a credit union that eliminated 82 per cent of its negative conversationWhy Reddit is the highest value listening channel for scientific brands, and what that means for AI visibilityHow to set response benchmarks in regulated sectors using a red, yellow and green triage system Chapters: [00:01] Welcome and introductions[01:23] What keeps Brooke busy at B Squared Media[02:18] The Facebook fundraiser that raised twelve times the average[06:52] Social listening as an alternative to the advisory board cycle[09:43] Return on conversation explained[12:57] Why broadcasting fails to build relationships[14:04] Creating conversation when scientists will not post publicly[18:07] The biggest thing marketers have to unlearn[19:09] The BIC method for social listening[23:00] Confirmation bias in voice of customer work[25:57] Where to start when nobody is talking about your brand[27:58] Reddit as the underused listening channel[31:11] Response time benchmarks in regulated sectors[36:01] First time response and the spectator effect[38:37] Where emotion enters an eighty thousand dollar buying decision[43:09] What surprises Brooke most about scientific brands If this episode changed how you think about your social budget, watch to the end, subscribe for new episodes of A Splice of Life Science Marketing, and visit https://strivenn.com for more on buyer presence and commercialisation in the life sciences.

    S2 Ep 32 Return on Conversation: Brooke B. Sellas talks social listening and life sciences marketing

  5. Sep 7

    S2 Ep31: Photocopying the Photocopy: AI's Sea of Sameness

    A paper in Nature found that models trained on model-generated data degrade one generation at a time, until the output collapses towards sameness. The same thing is happening to marketing teams, because everyone is drawing from the same public pool and buying the same four-workstream implementation playbook. Who this is for: commercial and marketing leaders at life science tools and diagnostics companies who are being asked what AI changes about their competitive position. Matt Wilkinson and Jasmine Gruia-Gray work through why intelligence has become cheap while truth and trust have become scarce. They cover the convergence problem across models and consultancies, why 80 to 90 percent of company data sits unstructured and unread, and what a question first approach to unlocking it looks like in practice. Matt also sets out where grounded synthetic customers fit, and Jasmine makes the case for the conference booth as the most under-recorded source of buyer language in the business. Key idea: models and the consultants deploying them are converging on the same public information, so the customer knowledge your organisation already owns is the last durable advantage you have. What you will learn Why model collapse and consulting convergence produce the same commercial outcome for your category Why having voice of customer research is different from having it turn up where decisions get made How to run a question first approach to unstructured data instead of a twelve month mapping exercise Where grounded synthetic customers earn their place across R and D, positioning and sales enablement How to read secondary market research reports without believing the absolute numbers Why a social media storm now gets regurgitated inside large language models long after it passes What a marketing or product leader can do in the next fortnight with the data already sitting in the CRM Chapters [00:04] Welcome and end of summer catch-up [00:40] Model collapse: photocopying a photocopy [01:46] The untouched pool sitting next to the public one [03:10] Watermarking, the EU AI Act and the consulting convergence [05:41] Data silos as the enterprise's next big challenge [05:56] You have voice of customer, but does it turn up where it matters [07:37] Question first, and grounded synthetic customers [09:04] Where to start and which data to prioritise [11:34] The ten year old problem hiding in your messaging [12:08] Secondary market research reports and social listening [14:29] Social media storms now live inside the models [14:54] The conference booth conversations nobody captures [15:39] Recording, privacy and better trade show follow-up [17:31] What to do in the next couple of weeks [19:38] Truth and trust in one sentence [20:49] The Buyer in the Loop and close Keywords life science marketing, model collapse, unstructured data, voice of customer, grounded synthetic customers, AI convergence, EU AI Act, market research reports, trade show follow-up, product marketing, competitive moat, buyer insight If this was useful, watch to the end, subscribe for new episodes of A Splice of Life Science Marketing, and read the full piece at strivenn.com/thinking. Matt's book, The Buyer in the Loop, goes deeper on keeping the buyer present through the whole commercial process.

  6. Aug 31

    S2 Ep30: Forty percent fail: Why it's not about money or talent

    Why 2 in 5 launched products fail commercially, and why it's not about money or talent—it's about asking the right questions. For example: Coca-Cola ran 190,000 blind taste tests before reformulating its flagship product. The research was rigorous. The result was catastrophic. They asked the wrong question. Who this is for: Product managers, marketing leaders, and commercial strategists at life science tools and diagnostics firms who own launch success and want to understand why process matters more than budget or talent. What the conversation covers: Matt and Jasmine explore why roughly 2 in 5 products that reach the market fail commercially, and why top-performing companies succeed at a rate of 76% while everyone else sits at 54%. The gap is not market conditions. It is process. Specifically, it is whether organisations ask the right questions of the right people before launch. The key idea: Rigorous research with the wrong question fails just as badly as no research at all. What you will learn: Why the commonly cited failure rates (90%, 3,000 ideas per success) are mythology, and what the actual data shows.How top-performing companies achieve 76% commercial success on product launches while competitors fail at 46%.Why failure in life science tools has a signature: customers never get pinned down, and evidence gets generated to satisfy internal reviewers rather than move purchase decisions.The mechanism of message drift: how products move away from the buyer as they move through approval cycles, and why people with the most approval authority are furthest from the customer.How synthetic customers built from your own win-loss data can surface what you have forgotten to ask, and where that approach falls short.Three tools for getting closer to the right question: articulating assumptions clearly, pre-mortems that stress-test failure scenarios, and small pilots before full product launch.Chapters: [00:02] The Coca-Cola paradox: 190,000 taste tests, one catastrophe[00:25] The lesson everyone gets wrong: it is not about listening, it is about asking[02:54] Untangling the myths: 90% failure vs. 40% vs. 3,000 ideas[05:59] The 40% that actually holds up, and the 76% that separates top performers[07:16] Why failure is a process variable, not a market condition[08:30] How approval cycles pull the message away from the buyer[10:00] Grounded synthetic customers and the echo chamber problem[15:06] Why Coca-Cola asked a preference question when it needed to ask a purchase question[17:57] What to do at a stage gate review without synthetic customers[18:53] Pre-mortems: stress-testing assumptions through failure scenarios[20:24] Why pilots matter more than large-scale rollouts[21:09] Resources: The Buyer in the Loop and Strivenn's approach Keywords: product launch failure, market research, product development, new product introduction, life science tools, synthetic customers, stage gates, voice of customer, buyer research, product definition, commercial success, Coca-Cola case study, pre-mortem, product roadmap The full blog post is on Strivenn's website: strivenn.com/thinking/two-in-five-launched-products-fail-commercially All citations for the data used in this episode are included there. Subscribe to A Splice of Life Science Marketing for weekly conversations on how to keep buyers in the room when everything else pulls you away from them.

  7. Aug 25

    S2 Ep29: The $50k Question" Boards, Buyers and the Switch Costs Nobody Measures

    Your scientific advisory board just told you the product works. It never told you whether anyone in that building is allowed to buy it. Who this is for: Product managers and product marketing leaders selling into life science tools and diagnostics accounts. Matt and Jasmine unpack why glowing feedback from a scientific advisory board so often gets mistaken for a buying signal. They walk through how purchase size changes who actually holds approval, why 40 to 60 percent of qualified B2B deals end in no decision at all, and how a simple pre-mortem exercise surfaces the objections a formal board will never say out loud. Key idea: The real competitor isn't another platform, it's the buyer's inability to make switching feel safe enough to approve. Why a scientifically enthusiastic panel is not the same as a buying committeeHow purchase size, roughly the line around $100k, changes who signs offWhat Dixon and McKenna's research on B2B no-decision means for life science salesHow to spot the gap by asking R&D partners pointed commercial questionsWhy a Gary Klein style pre-mortem gets more honest objections than a formal boardHow to reframe one advisory board agenda to include buyer's journey questions[00:20] Intro[00:49] The other half of the PM job[02:00] Where the gap shows up: the ELISA panel example[04:56] The case for a commercial advisory board[05:40] People problem or process problem[06:33] How to spot this happening to you[07:30] $50k versus $400k: does the same board reach both[08:58] Inside a CapEx committee[09:39] Dixon and McKenna: 40 to 60 percent no decision[11:01] Getting out of the office to find the real answer[11:51] The pre-mortem alternative[13:01] The one question that cuts across all of it[14:04] Where to find the full piece[14:39] The real competitor Keywords: scientific advisory board, commercial advisory board, product management, life science marketing, buyer's journey, B2B no decision, switching costs, CapEx committee, procurement, pre-mortem, stage gate, buyer indecision Watch the full conversation, subscribe for more life science marketing strategy, and visit https://strivenn.com/thinking/your-advisory-board-answers-science-questions for the complete piece. Book a call with the Strivenn team at https://strivenn.com/contact if you want help preparing for these commercial questions.

  8. Aug 19

    S2 Ep28: Marketing's Seventh Wave: Why the Buyer Is the Bottleneck

    The pipes for AI are already in the ground. Everything slowing the seventh wave down now sits inside your organisation and inside your buying group, and none of it is a technology problem. Who this is for: life science marketers, product leaders and commercial teams being asked what AI actually changes about their go-to-market. Matt Wilkinson and Jasmine Bar-Kochva work through Matt's blog post, Marketing's Seventh Wave Has a Buyer Problem, mapping seven waves of marketing from mass production in the 1880s to generative and agentic AI in 2023. They cover why the installation phase for this wave is so much shorter than the ones before it, what is really blocking adoption inside businesses, and why personas built by internal consensus stopped being fit for purpose. The conversation ends on change fatigue and the emotional context that decides whether a deal closes.

See All (40)

About

Welcome to the Splice of Life Science Marketing Podcast. With your hosts Matt Wilkinson and Jasmine Gruia-Gray. This is the show for scientists who've stepped out of the lab and into marketing, learning the ropes as they go.

Information

  • Creator
    Matt Wilkinson and Jasmine Griuia-Gray | Strivenn
  • Years Active
    2026
  • Episodes
    40
  • Rating
    Clean
  • Copyright
    © Matt Wilkinson and Jasmine Griuia-Gray | Strivenn
  • Show Website
    A Splice of Life Science Marketing